Clinical efficacy of robot-assisted Wallace ileal conduit in the treatment of ureteral obstruction after radical cystectomy
10.3969/j.issn.1009-8291.2025.10.008
- VernacularTitle:机器人辅助Wallace法回肠通道术治疗根治性膀胱切除术后输尿管梗阻的疗效分析
- Author:
Tianxiao HONG
1
;
Chaoran ZHAO
;
Rongjie BAI
;
Pengchao LI
Author Information
1. 南京医科大学第一附属医院泌尿外科,江苏南京 210029
- Publication Type:Journal Article
- Keywords:
radical cystectomy;
urinary diversion;
ureteral obstruction;
Wallace ileal conduit;
robot-assisted surgery
- From:
Journal of Modern Urology
2025;30(10):860-864
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the feasibility and efficacy of robot-assisted Wallace ileal conduit in the treatment of ureteral obstruction following radical cystectomy.Methods A retrospective analysis was conducted on the clinical data of 8 patients with postoperative distal ureteral obstruction after radical cystectomy treated at the First Affiliated Hospital of Nanjing Medical University during Aug.2018 and Jun.2024.The cohort included 7 males and 1 female,aged 51-68 years(mean:58.8 years).Preoperative imaging confirmed the obstruction site and predicted its etiology.All patients underwent robot-assisted Wallace ileal conduit and were regularly followed postoperatively.Perioperative data were statistically analyzed.Results All 8 procedures were successfully completed.The operation time ranged from 120 to 398 minutes(mean:298.38 minutes),and intraoperative blood loss from 50 to 300 mL(mean:112.5 mL).Postoperative complications occurred in 3 cases according to the Clavien-Dindo classification:one Grade Ⅰ and two Grade Ⅱ,with no major postoperative complications(Grade Ⅲ and above)observed.During a follow-up of 21-77 months,hydronephrosis and renal function showed varying degrees of improvement.Conclusion Robot-assisted Wallace ileal conduit is safe,feasible,and effective in the treatment of ureteral obstruction following radical cystectomy.However,for malignant obstruction caused by tumor recurrence,combined comprehensive therapy is necessary to reduce recurrence risk.